Missed Insights for Earlier Management of Parkinson's Disease and the Value of Dopamine Transporter (DAT) Scans
- PMID: 39451858
- PMCID: PMC11507427
- DOI: 10.3390/geriatrics9050126
Missed Insights for Earlier Management of Parkinson's Disease and the Value of Dopamine Transporter (DAT) Scans
Abstract
Background/Objectives: This retrospective study focused on the role of Dopamine Transporter (DAT) scans in diagnosing Parkinson's Disease (PD) in older adults with cognitive impairment (CI). Methods: We retrospectively analyzed brain imaging of 6483 individuals aged 60 and above with CI. Among these, 297 underwent a DAT scan, with 189 testing positive and 89 starting dopamine therapy. In contrast, 173 patients exhibited PD-associated structural changes on CT or MRI without receiving DAT scans or treatment. Results: Of these patients, 50 (29%) experienced falls. This points towards a potential missed diagnosis of PD, which can respond to therapy in the early stages. Conclusions: Our results suggest that providers may overlook subtle signs of parkinsonism in patients with CI, resulting in symptoms worsening and treatment delay. Since CI is often first brought to the attention of PCPs, our findings call for an increased effort to inform PCPs of the role of DAT scans in aiding the diagnosis of dopamine deficiency states. By understanding PD-related structural changes seen on brain imaging and using a DAT scan to confirm dopamine deficiency, treatment for PD or related states might be started earlier or a timely referral made to a specialist, reducing patient disability and improving their quality of life.
Keywords: Parkinson’s disease; cognitive impairment; dopamine transporter scan; early diagnosis; falls; geriatric neurology; neuroimaging.
Conflict of interest statement
The authors declare no conflicts of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.
Figures



Similar articles
-
Multimodal dopamine transporter (DAT) imaging and magnetic resonance imaging (MRI) to characterise early Parkinson's disease.Parkinsonism Relat Disord. 2020 Oct;79:26-33. doi: 10.1016/j.parkreldis.2020.08.010. Epub 2020 Aug 17. Parkinsonism Relat Disord. 2020. PMID: 32861103 Review.
-
The predictive value of transcranial sonography in clinically diagnosed patients with early stage Parkinson's disease: comparison with DAT PET scans.Neurosci Lett. 2014 Oct 17;582:99-103. doi: 10.1016/j.neulet.2014.08.053. Epub 2014 Sep 10. Neurosci Lett. 2014. PMID: 25218716
-
Dopamine transporter single photon emission computed tomography (DaT-SPECT) use in the diagnosis and clinical management of parkinsonism: an 8-year retrospective study.J Neurol. 2023 May;270(5):2550-2558. doi: 10.1007/s00415-023-11563-y. Epub 2023 Feb 16. J Neurol. 2023. PMID: 36795149 Free PMC article.
-
Effect of striatal dopamine depletion on cognition in de novo Parkinson's disease.Parkinsonism Relat Disord. 2018 Jun;51:43-48. doi: 10.1016/j.parkreldis.2018.02.048. Epub 2018 Mar 2. Parkinsonism Relat Disord. 2018. PMID: 29526657
-
Striatal Dopamine Loss in Early Parkinson's Disease: Systematic Review and Novel Analysis of Dopamine Transporter Imaging.Mov Disord Clin Pract. 2023 Feb 17;10(4):539-546. doi: 10.1002/mdc3.13687. eCollection 2023 Apr. Mov Disord Clin Pract. 2023. PMID: 37070042 Free PMC article. Review.
References
-
- Kouli A., Torsney K.M., Kuan W.L. Parkinson’s Disease: Pathogenesis and Clinical Aspects. Exon Publications; Brisbane, Australia: 2018. Parkinson’s Disease: Etiology, Neuropathology, and Pathogenesis. - DOI
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous